• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 13B; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 13B; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number LXMC13
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dysphagia/ Odynophagia (1815); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Only event year known: 2018.As a lot was not provided, a device history could not be performed.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Is the lot number available for the lxmc13? on what date did the explant take place? did the patient have an autoimmune disease? is the patient currently taking steroids / immunization drugs? did the patient have any pre-existing dysphagia or other conditions (other than gerd)? how severe was the dysphagia/odynophagia before intervention? did the dysphagia improve after the device was implanted initially? were there any intra-operative complications during implant? was there any hiatal or crural repair done at the same time as the implant? what was the reason for removal of the linx device? was the device found in the correct position/geometry at the time of removal? what is the current status of the patient?.
 
Event Description
It was reported that the device was implanted on a female patient one month ago and she was having persistent dysphagia.He mentioned he tried her on po steroids for one week along with a course of iv steroids and he dilated her esophagus with no improvement in symptoms.He mentioned she had a previous history of a cervical spine injury with a fusion which may be leading to some dysmotility.He also mentioned her motility study prior to linx showed 80% effective swallows.Patient is now an inpatient and unable to eat so he made decision to remove linx device.Linx 13 device was removed without difficulty or patient complications.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).Additional information was requested, and the following was obtained: is the lot number available for the lxmc13? 18883 - on what date did the explant take place? (b)(6) 2018.- did the patient have an autoimmune disease? no.- is the patient currently taking steroids / immunization drugs? no.- did the patient have any pre-existing dysphagia or other conditions (other than gerd)? no - how severe was the dysphagia/odynophagia before intervention? n/a.- did the dysphagia improve after the device was implanted initially? n/a.- were there any intra-operative complications during implant? no.- was there any hiatal or crural repair done at the same time as the implant? yes - what was the reason for removal of the linx device? dysphagia due to poor.Esophageal contraction.Patient had cervical fusion in the past, that may have caused esophageal dysmotility that was not really evidenced prior to surgery.- was the device found in the correct position/geometry at the time of removal? yes.
 
Manufacturer Narrative
(b)(4).Date sent: 03/27/2019.Device analysis: overall review of the device function and dimensions show no anomalies from a device that has been reasonably changed as part of the explant procedure.Visual analysis was consistent with an explanted device, and link length and tensile force were found to meet the applicable specifications.Overall, no analysis conclusions relevant to the patient experience were found.The dhr of lot 18883 was reviewed.No defects, ncrs, or reworks were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 13B
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
MDR Report Key8164237
MDR Text Key130342954
Report Number3008766073-2018-00221
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005332
UDI-Public00855106005332
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup
Report Date 12/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/25/2022
Device Catalogue NumberLXMC13
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer02/05/2019
Initial Date Manufacturer Received 12/04/2018
Initial Date FDA Received12/14/2018
Supplement Dates Manufacturer Received01/09/2019
02/05/2019
03/21/2019
Supplement Dates FDA Received01/11/2019
02/26/2019
03/27/2019
Patient Sequence Number1
-
-